Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
nsclc targeted therapy drugs | 0.38 | 0.9 | 413 | 88 | 28 |
nsclc | 1.79 | 0.6 | 4330 | 67 | 5 |
targeted | 1.86 | 0.2 | 7461 | 52 | 8 |
therapy | 1.48 | 0.6 | 3494 | 65 | 7 |
drugs | 0.85 | 0.6 | 7984 | 41 | 5 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
nsclc targeted therapy drugs | 0.24 | 0.1 | 2130 | 36 |
target therapy for nsclc | 1.97 | 0.4 | 9652 | 98 |
neoadjuvant targeted therapy in nsclc | 0.88 | 1 | 475 | 59 |
adjuvant targeted therapy nsclc | 1.57 | 0.2 | 5616 | 8 |
current drugs approved for treatment of nsclc | 1.93 | 0.5 | 5982 | 36 |
targeted therapy for sclc | 0.28 | 0.8 | 6038 | 86 |
drugs used to treat nsclc | 1.73 | 0.1 | 1877 | 38 |
immunotherapy drugs for nsclc | 1.05 | 0.6 | 3459 | 71 |
drugs approved for nsclc | 0.47 | 0.7 | 1525 | 84 |
new treatments for nsclc | 1.96 | 0.3 | 4661 | 34 |
fda approved treatment for nsclc | 1.45 | 0.2 | 578 | 79 |
list of immunotherapy drugs for nsclc | 1.91 | 1 | 2480 | 98 |
new treatments for nsclc cancer | 0.77 | 0.3 | 8940 | 48 |
clinical trials for nsclc | 0.52 | 0.4 | 9490 | 6 |
drugs approved for metastatic nsclc | 1.12 | 0.8 | 6641 | 90 |
nsclc treatment by stage | 1.08 | 0.1 | 3716 | 80 |
radiation therapy for nsclc | 1.22 | 1 | 2628 | 5 |
nsclc diabetes treatments inhibitors | 0.23 | 0.1 | 5265 | 53 |
treatment guidelines for nsclc | 0.67 | 0.6 | 2779 | 73 |
new treatment options for advanced nsclc | 1.82 | 0.6 | 282 | 69 |
nsclc stage 4 clinical trials | 0.49 | 0.6 | 9415 | 83 |
second line treatment for nsclc | 0.88 | 0.1 | 4773 | 27 |